Abbott Laboratories
(ETR) ABL
Abbott Laboratories Financials at a Glance
Market Cap
$158.42B
Revenue (TTM)
$44.33B
Net Income (TTM)
$6.52B
EPS (TTM)
$3.28
P/E Ratio
27.78
Dividend
$2.08
Beta (Volatility)
0.05 (Low)
Dividend
$2.08
Beta (Volatility)
0.05 (Low)
Price
$91.17
Volume
599
Open
$91.06
Price
$91.17
Volume
599
Open
$91.06
Previous Close
$91.17
Daily Range
$90.74 - $91.17
52-Week Range
$88.57 - $123.64
Dividend
$2.08
Beta (Volatility)
0.05 (Low)
Price
$91.17
Volume
599
Open
$91.06
Previous Close
$91.17
Daily Range
$90.74 - $91.17
52-Week Range
$88.57 - $123.64
ABL News
ABL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Abbott Laboratories
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
115,000
CEO
Robert B. Ford, MBA
Website
www.abbott.comHeadquarters
North Chicago, IL 60064-6400, US
ABL Financials
Key Financial Metrics (TTM)
Gross Margin
56%
Operating Margin
18%
Net Income Margin
15%
Return on Equity
13%
Return on Capital
11%
Return on Assets
8%
Earnings Yield
3.60%
Dividend Yield
0.02%
Payout Ratio
63.09%
Stock Overview
Market Cap
$158.42B
Shares Outstanding
1.74B
Volume
599
Short Interest
0.00%
Avg. Volume
1.06K
Financials (TTM)
Gross Profit
$25.14B
Operating Income
$8.39B
EBITDA
$8.65B
Operating Cash Flow
$9.57B
Capital Expenditure
$2.17B
Free Cash Flow
$7.40B
Cash & ST Invst.
$8.94B
Total Debt
$15.07B
Abbott Laboratories Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$11.46B
+4.4%
Gross Profit
$6.63B
+9.8%
Gross Margin
57.82%
N/A
Market Cap
$158.42B
N/A
Market Cap/Employee
$1.39M
N/A
Employees
114,000
N/A
Net Income
$1.78B
-80.8%
EBITDA
$3.16B
+6.4%
Quarterly Fundamentals
Net Cash
$6.13B
+13.1%
Accounts Receivable
$7.93B
-16.5%
Inventory
$6.49B
+4.8%
Long Term Debt
$11.76B
-13.0%
Short Term Debt
$3.31B
+120.6%
Return on Assets
7.52%
N/A
Return on Invested Capital
11.46%
N/A
Free Cash Flow
$2.63B
+22.3%
Operating Cash Flow
$3.32B
+15.6%